Norton L - Search Results

1

BRCA-associated breast cancer: absence of a characteristic immunophenotype.

Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, Haas B, Norton L, Offit K. Robson M, et al. Among authors: norton l. Cancer Res. 1998 May 1;58(9):1839-42. Cancer Res. 1998. PMID: 9581822

2

Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis.

Rosen PP, Lesser ML, Arroyo CD, Cranor M, Borgen P, Norton L. Rosen PP, et al. Among authors: norton l. Cancer. 1995 Mar 15;75(6):1320-6. doi: 10.1002/1097-0142(19950315)75:6<1320::aid-cncr2820750614>3.0.co;2-c. Cancer. 1995. PMID: 7882282

3

BRCA-associated breast cancer in young women.

Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, Hirschaut Y, Pressman P, Rosen PP, Lesser ML, Norton L, Offit K. Robson M, et al. Among authors: norton l. J Clin Oncol. 1998 May;16(5):1642-9. doi: 10.1200/JCO.1998.16.5.1642. J Clin Oncol. 1998. PMID: 9586873

4

Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.

Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, Haas B, Osborne M, Norton L, Gilbert F, Offit K. Robson M, et al. Among authors: norton l. Genet Test. 1997;1(1):47-51. doi: 10.1089/gte.1997.1.47. Genet Test. 1997. PMID: 10464625

5

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

Robson M, Levin D, Federici M, Satagopan J, Bogolminy F, Heerdt A, Borgen P, McCormick B, Hudis C, Norton L, Boyd J, Offit K. Robson M, et al. Among authors: norton l. J Natl Cancer Inst. 1999 Dec 15;91(24):2112-7. doi: 10.1093/jnci/91.24.2112. J Natl Cancer Inst. 1999. PMID: 10601383

6

Immunophenotype of intraductal carcinoma.

Bose S, Lesser ML, Norton L, Rosen PP. Bose S, et al. Among authors: norton l. Arch Pathol Lab Med. 1996 Jan;120(1):81-5. Arch Pathol Lab Med. 1996. PMID: 8554451

7

Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.

Rosen PP, Groshen S, Kinne DW, Norton L. Rosen PP, et al. Among authors: norton l. J Clin Oncol. 1993 Nov;11(11):2090-100. doi: 10.1200/JCO.1993.11.11.2090. J Clin Oncol. 1993. PMID: 8229123

8

Immunohistochemical detection of cathepsin D in T2N0M0 breast carcinoma.

Armas OA, Gerald WL, Lesser ML, Arroyo CD, Norton L, Rosen PP. Armas OA, et al. Among authors: norton l. Am J Surg Pathol. 1994 Feb;18(2):158-66. doi: 10.1097/00000478-199402000-00005. Am J Surg Pathol. 1994. PMID: 8291654

9

Germline BRCA1 185delAG mutations in Jewish women with breast cancer.

Offit K, Gilewski T, McGuire P, Schluger A, Hampel H, Brown K, Swensen J, Neuhausen S, Skolnick M, Norton L, Goldgar D. Offit K, et al. Among authors: norton l. Lancet. 1996 Jun 15;347(9016):1643-5. doi: 10.1016/s0140-6736(96)91484-1. Lancet. 1996. PMID: 8642955

10

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.

Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K. Neuhausen S, et al. Among authors: norton l. Nat Genet. 1996 May;13(1):126-8. doi: 10.1038/ng0596-126. Nat Genet. 1996. PMID: 8673092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,011 results

Search Page

Filters